Marks a world-first as Regentis uses MOCART, a quantitative standard to measure regeneration of cartilage in a clinical ...
I write further to the recent public discourse surrounding the Presidential Task Force appointed to oversee rehabilitation, ...
Scientists at Stanford Medicine have reported a discovery that could change how arthritis and joint damage are treated. In experiments on animals and human tissue, researchers found that blocking a ...
TipRanks on MSN
Regentis Biomaterials publishes Phase II data showing long-term durability of GelrinC cartilage repair
Regentis Biomaterials Ltd ( ($RGNT) ) has shared an announcement. On January 6, 2025, Regentis Biomaterials announced peer-reviewed publication of ...
Regentis Biomaterials (RGNT) announced publication of long-term follow-up results from its successfully concluded Phase II clinical trial of ...
Marks a world-first as Regentis uses MOCART, a quantitative standard to measure regeneration of cartilage in a clinical trial, as a predefined endpointNew peer-reviewed data published in the scientifi ...
Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company pioneering first-in-class therapeutics based on small-molecule inhibition of CLK/DYRK kinases, announced today that ...
The treatment also prevented the development of arthritis after knee injuries such as ACL tears often experienced by athletes ...
Knee cartilage usually wears down quietly. Over time, that loss can turn walking stairs into a daily calculation.
A treatment that blocks an age-related protein restored cartilage in aging and injured joints by reprogramming existing cells ...
Hyaline cartilage is primarily composed of a specialized extracellular matrix (ECM) and sparsely distributed cells called chondrocytes. The ECM, a complex network of macromolecules, provides the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback